Advertisement

Topics

Amyris, Inc. Company Profile

19:07 EDT 21st September 2017 | BioPortfolio

Amyris is building an integrated renewable products company by applying industrial synthetic biology to genetically modify microorganisms to serve as living factories. Amyris designs these microorganisms to produce defined molecules for use as renewable chemicals and transportation fuels. Amyris Brasil S.A., a subsidiary of Amyris, oversees the establishment and expansion of Amyris’s production in Brazil, including SMA Indústria Química S.A., its joint venture with São Martinho. In addition, Amyris is building fuels distribution capabilities in the United States through its subsidiary, Amyris Fuels LLC. More information about Amyris and its subsidiaries is available at www.amyris.com.


News Articles [32 Associated News Articles listed on BioPortfolio]

INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 23, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Amyris, Inc. ("Amyris" or the "Company") (NASDAQ: AMRS) concerning ...

EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 10, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Amyris, Inc. ("Amyris" or the "Company") (NASDAQ: AMRS) concerning p...

UPCOMING DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 7, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Amyris, Inc. ("Amyris" or the "Company") (NASDAQ: AMRS) for possible...

EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 1, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Amyris, Inc. ("Amyris" or the "Company") (NASDAQ: AMRS) for possible...

3-DAY DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 16, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Amyris, Inc. ("Amyris" or the "Company") (NASDAQ: AMRS) for possib...

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 17, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Amyris, Inc. ("Amyris" or the "Company") (NASDAQ: AMRS) concerning p...

SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 30, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Amyris, Inc. ("Amyris" or the "Company") (NASDAQ: AMRS) concerning p...

Amyris Biossance Launches in SEPHORA Canada Stores

EMERYVILLE, Calif., July 26, 2017 (GLOBE NEWSWIRE) — Biossance™, the consumer beauty brand from Amyris, Inc. (NASDAQ:AMRS), today announced that it will expand to SEPHORA in over 60 SEPHORA lo...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Amyris, Inc.

Amyris is building an integrated renewable products company by applying industrial synthetic biology to genetically modify microorganisms to serve as living factories. Amyris desi...

Amyris Biotechnologies Inc.

Amyris Biotechnologies, Inc.

Amyris Biotechnologies is focused on translating the promise of synthetic biology into solutions for real-world problems. Applying advances in molecular biology, we have engineered microbes capable of...

OneWorld Health

The Institute for OneWorld Health is engaged in a unique drug development project to ensure consistent, affordable supplies of artemisinin, a key component of Artemisinin-Based Combination Therapies (...

More Information about "Amyris, Inc." on BioPortfolio

We have published hundreds of Amyris, Inc. news stories on BioPortfolio along with dozens of Amyris, Inc. Clinical Trials and PubMed Articles about Amyris, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Amyris, Inc. Companies in our database. You can also find out about relevant Amyris, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...


Corporate Database Quicklinks



Searches Linking to this Company Record